Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Annual fiscal-year EPS history; the page headline uses the current trailing EPS value. Historical series through 2025-12-31.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-0.27
EARNINGS PER SHARE (EPS) AVG 3Y
-0.33
EARNINGS PER SHARE (EPS) AVG 5Y
-0.45
EARNINGS PER SHARE (EPS) AVG 10Y
-0.32
EARNINGS PER SHARE (EPS) AVG 15Y
-0.44
EARNINGS PER SHARE (EPS) AVG 20Y
-1.93
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tiziana Life Sciences Ltd
Market Cap
$68.72M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.27
3Y Avg
-0.33
5Y Avg
-0.45
Market Cap
$68.68M
Earnings Per Share (EPS)
0.11
TTM Avg
-0.56
3Y Avg
-0.48
5Y Avg
-1.39
Market Cap
$68.60M
Earnings Per Share (EPS)
2.68
TTM Avg
-1.38
3Y Avg
-6.44
5Y Avg
-7.90
Market Cap
$69.05M
Earnings Per Share (EPS)
-0.08
TTM Avg
0.13
3Y Avg
-0.17
5Y Avg
-0.10
Market Cap
$66.13M
Earnings Per Share (EPS)
-5.01
TTM Avg
-7.16
3Y Avg
-89.38
5Y Avg
-71.00
Market Cap
$66.24M
Earnings Per Share (EPS)
-0.33
TTM Avg
-1.03
3Y Avg
-28.69
5Y Avg
-510.63
Market Cap
$71.02M
Earnings Per Share (EPS)
-0.50
TTM Avg
-0.75
3Y Avg
-1.17
5Y Avg
-1.06
Market Cap
$66.01M
Earnings Per Share (EPS)
-1.48
TTM Avg
-1.38
3Y Avg
-1.16
5Y Avg
-0.93
Market Cap
$65.17M
Earnings Per Share (EPS)
-55.66
TTM Avg
-39.81
3Y Avg
-97.72
5Y Avg
-154.19
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tiziana Life Sciences Ltd (TLSA) | $68.72M | N/A | -0.27 | -0.33 | -0.45 |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.68M | 0.11 | -0.56 | -0.48 | -1.39 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 2.68 | -1.38 | -6.44 | -7.90 |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | -0.08 | 0.13 | -0.17 | -0.10 |
| Cingulate Inc. (CING)vs › | $66.13M | -5.01 | -7.16 | -89.38 | -71.00 |
| iBio, Inc. (IBIO)vs › | $66.24M | -0.33 | -1.03 | -28.69 | -510.63 |
| Gain Therapeutics, Inc. (GANX)vs › | $71.02M | -0.50 | -0.75 | -1.17 | -1.06 |
| XBiotech Inc. (XBIT)vs › | $66.01M | -1.48 | -1.38 | -1.16 | -0.93 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.17M | -55.66 | -39.81 | -97.72 | -154.19 |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.76M | -1.74 | -8.23 | -9.60 | -11.41 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.32 |
| 2024-12-31 | -0.22 |
| 2023-12-31 | -0.42 |
| 2022-12-31 | -0.36 |
| 2021-12-31 | -0.64 |
| 2020-12-31 | -0.74 |
| 2019-12-31 | -0.14 |
| 2018-12-31 | -0.12 |
| 2017-12-31 | -0.16 |
| 2016-12-31 | -0.17 |
| 2015-12-31 | -0.27 |
| 2014-12-31 | -0.97 |
| 2013-12-31 | -0.04 |
| 2012-12-31 | -1.53 |
| 2011-12-31 | -1.83 |
| 2010-12-31 | -13.51 |
| 2009-12-31 | -11.38 |
| 2008-12-31 | -63.52 |
| 2007-12-31 | -271.38 |
| 2006-12-31 | -335.76 |
| 2005-12-31 | -451.74 |
| 2004-12-31 | -480.58 |
| 2003-12-31 | -748.05 |
| 2002-12-31 | -1612.90 |
| 2001-12-31 | -3230.14 |
| 2000-12-31 | -4135.31 |
| 1999-12-31 | -1077.17 |
| 1998-12-31 | -527.03 |
